CSIMarket Company Name, Ticker, Customers, else..
 
Zimmer Biomet Holdings Inc   (ZBH)
Other Ticker:  
 
 

Zimmer Biomet Holdings Inc Growth Comparisons

Select each growth Category to receive further Information



ZBH Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 5.02 % 5.39 % -0.27 % -0.65 %
Q / Q Revenue Growth (Q3 MRQ) -6.2 % 0.13 % 0.42 % -1.14 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 1.77 % 6.99 % - %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 1.16 % 1.25 % - 0.04 %
Revenue 5 Year Average Growth -2.37 % 7.83 % 10.73 % 11.04 %


ZBH's Growth Comparisons in III. Quarter 2023




Comparing 5.02% year on year top-line growth in the third quarter 2023, Zimmer Biomet Holdings Inc grew on the lower pace than the 5.39% growth in the Medical Equipment & Supplies industry, but beating the -0.27% decrease in the Healthcare sector. Above the average sales gains in the Healthcare and in the Medical Equipment & Supplies industry as well, helped to elevate overall market growth to -0.65%.

Top-line fell by -6.2% from the second quarter. Average annual sales growth for Zimmer Biomet Holdings Inc is -2.37%, while S & P 500's average yearly sales increase is 11.04%, including only Businesses with the third quarter 2023 financial results.

ZBH Growth Rates by Company's Segments

Sales & Income Growth Rates
Y / Y
Seq.
Y / Y
Seq.
Total
5.02 %
-6.2 %
-16.12 %
-22.35 %


Growth Rates of ZBH's Income in the third quarter 2023


ZBH Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 8.68 % -41.02 % -41.58 % 0.62 %
Seq. Operating Income Change (Q3 MRQ) -19.11 % - 37.49 % 7.87 %
Y / Y Operating Income Growth (Q3 TTM) 11.38 % -63.26 % -25.94 % -9.48 %
Seq. Operating Income Growth (Q3 TTM) 2.44 % -20.89 % -12.45 % -0.31 %
Operating Income 5 Year Avg. Change -2.94 % -2.51 % 10.09 % 10.67 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) -16.12 % -44.21 % -78.91 % 1.43 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) -22.35 % - 415.47 % 11.41 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) 40.8 % -76.51 % -56.92 % -9.41 %
Seq. Income from Cont. Ops. Change (Q3 TTM) -6.18 % -19.26 % -32.24 % 0.17 %
Income from Cont. Ops. 5 Year Avg. Change -30.64 % -1.51 % 23.08 % 2.84 %

ZBH Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) -16.12 % 54.32 % 6.22 % 7.1 %
Q / Q Net Income Growth (Q3 MRQ) -22.35 % - 2720.54 % 15.58 %
Y / Y Net Income Change (Q3 TTM) 70.51 % -59.59 % -32.8 % -7.15 %
Seq. Net Income Change (Q3 TTM) -6.18 % 35.79 % 3.22 % 1.71 %
Net Income 5 Year Avg. Growth -33.69 % -1.69 % 23.1 % 3.14 %

ZBH's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) -15.22 % -48.76 % -78.91 % 1.43 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) -22 % - 415.47 % 11.41 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 41.92 % - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) -5.81 % - - 117.26 %
EPS from Cont. Ops. 5 Year Avg. Growth -31.24 % -17.56 % 23.08 % 2.84 %



ZBH EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) -16.3 % 41.73 % 6.22 % 2.84 %
Q / Q EPS Net Growth (Q3 MRQ) -23 % - 2720.54 % 15.58 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 60266.88 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) -6.23 % - - 115.79 %
EPS Net 5 Year Avg. Change - -1.69 % 23.1 % 3.14 %



Zimmer Biomet Holdings Inc 's sharp decrease of -16.3% in income per share in the third quarter from the same quarter a year ago, those results deviated strongly from the rising EPS in Medical Equipment & Supplies industry with 41.73%, and underperformed the 6.22% EPS growth in the Healthcare sector. Comparing third quarter, income per share Zimmer Biomet Holdings Inc was trailing overall market not just Medical Equipment & Supplies industry.

Comparing the company's EPS to the second quarter results, income per share were lower by -23% . On the annual basis, average annual income per share growth for Zimmer Biomet Holdings Inc is -2.37%, while S & P 500's including only Businesses with the third quarter 2023 financial reports, average yearly income per share growth is 3.14% over the past five years.

ZBH Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) -25.11 % 29.41 % 4.89 % 25.55 %
Seq. Free Cash Flow Change (Q3 MRQ) -2.96 % 21.5 % 51.69 % 29.02 %
Y / Y Free Cash Flow Change (Q3 TTM) -16.26 % 15.93 % -9.09 % -3.19 %
Seq. Free Cash Flow Change (Q3 TTM) -8.38 % 6.46 % 2.26 % 11.89 %
Free Cash Flow 5 Year Avg. Change -3.91 % -4.48 % 18.45 % 23.35 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - 224.09 % 8.27 % -
Seq. Net Cash Flow Change (Q3 MRQ) - 348.36 % - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Seq. Net Cash Flow Change (Q3 TTM) - 683.59 % 15.55 % -
Net Cash Flow 5 Year Avg. Change - - 0.58 % 48.92 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 106.36 % 12.72 % 3.28 % 69.67 %
Seq. Capital Expenditures Change (Q3 MRQ) -42.91 % 16.35 % 5.56 % 16.42 %
Y / Y Capital Expenditures Change (Q3 TTM) 92.91 % 9.04 % 5.41 % -8.48 %
Seq. Capital Expenditures Change (Q3 TTM) 15.31 % 4.67 % 0.76 % 18.81 %
Capital Expenditures 5 Year Avg. Change 3.79 % 9.74 % 9.25 % 8.67 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com